Provincial Drug Administration went to Shaoguan to supervise and investigate epidemic prevention and control and high-quality development of the drug distribution industry
From November 17th to 18th, Yan Zhen, deputy director of the Provincial Drug Administration, led a team to Shaoguan to supervise and investigate the prevention and control of the epidemic and the high-quality development of the drug distribution industry. The supervision team listened to reports on the work of the Shaoguan City Market Supervision Bureau and the Municipal Drug Inspection Institute, visited local pharmaceutical and biomedical companies, and spot-checked some retail pharmacies and new coronavirus vaccination units.
When investigating pharmaceutical and biomedical companies, the supervision team emphasized the need to further implement the cooperation framework agreement for promoting biomedical innovation and development jointly signed by the Guangdong Provincial Drug Administration and the Shaoguan Municipal People’s Government, accelerate the construction of biomedical industry, research and research bases, and promote the promotion of biomedical technology. Use, speed up the development of the biomedical industry, and strive to build Shaoguan into a new highland for the innovation and development of biomedicine in our province.
The supervision team conducts supervision and inspection of the retail pharmacy “three inspections”, regular disinfection records of business premises, and the information registration report of drug personnel purchasing the “Catalogue of Drugs that Need to be Registered and Reported During Epidemic Prevention and Control”, and requires the supervisory department to compact the epidemic situation in retail pharmacies The main responsibility of prevention and control is to be cautious and to keep a close grip on prevention and control, resolutely overcome paralysis, war exhaustion, fluke, and relaxation mentality, learn experience and lessons, use high-probability thinking to deal with small-probability events, and implement normalization Epidemic prevention and control measures, continue to maintain the vigilance and sensitivity of “sentinel” monitoring.
The supervision team inspects the implementation of the new crown virus vaccine storage management system, facilities and equipment, handover, receipt and temperature monitoring records of the inoculation unit on site, and requires enterprises and inoculation units to strictly implement the main responsibilities to ensure that the new crown virus vaccine storage and transportation links are in compliance throughout the process Refrigeration conditions ensure the quality and safety of vaccines. At the same time, it is necessary to strengthen the monitoring of suspected vaccination abnormal reactions and report the relevant situation in a timely manner; the supervisory authority should earnestly fulfill the responsibility of territorial supervision, strengthen the supervision of the storage and transportation of the new crown virus vaccine, and the supervision work should be carried out. Pay close attention to the landing to ensure that “where the vaccine is stored and transported, the quality supervision will follow”, and resolutely maintain the quality and safety of vaccine storage and transportation. (Contribution/Picture of the Second Division of Drug Supervision and Administration of the Provincial Bureau)